<p>This second edition book explores breakthrough technologies in the field of drug target identification and validation. The volume emphasizes particularly revolutionary technologies, such as CRISPR-related screening, βbig data,β and <i>in silico</i> approaches, as well as <i>in vivo</i> applicatio
Target Identification and Validation in Drug Discovery: Methods and Protocols
β Scribed by Marta CortΓ©s-Cros, Tobias Schmelzle, Volker M. Stucke, Francesco Hofmann (auth.), Jurgen Moll, Riccardo Colombo (eds.)
- Publisher
- Humana Press
- Year
- 2013
- Tongue
- English
- Leaves
- 389
- Series
- Methods in Molecular Biology 986
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
The major reason for the elevated costs of drug development in the pharmaceutical industry is the high attrition rate. In Target Identification and Validation in Drug Discovery: Methods and Protocols, expert researchers in the field detail many of the methods which are now commonly used to identify and validate new target. These include methods and approaches covering biochemical, cell based, in vivo models and translational methods. Chapters also include selected case reports that demonstrate the integration of these technologies to real life experiences and to demonstrate the multiple use of more than one technology to increase knowledge on a specific target. These Written in the highly successful Methods in Molecular Biologyβ’ series format, the chapters include the kind of detailed description and implementation advice that is crucial for getting optimal results in the laboratory.
Thorough and intuitive, Target Identification and Validation in Drug Discovery: Methods and Protocols contains a comprehensive list of essential methods and clear protocols to follow.
β¦ Table of Contents
Front Matter....Pages i-xv
Front Matter....Pages 1-1
Front Matter....Pages 3-13
Front Matter....Pages 15-15
Front Matter....Pages 17-39
Front Matter....Pages 41-56
Front Matter....Pages 57-57
Front Matter....Pages 59-71
Back Matter....Pages 73-87
....Pages 89-95
β¦ Subjects
Pharmacology/Toxicology; Medicinal Chemistry
π SIMILAR VOLUMES
<p><p>The major reason for the elevated costs of drug development in the pharmaceutical industry is the high attrition rate. In <i>Target Identification and Validation in Drug Discovery: Methods and Protocols</i>, expert researchers in the field detail many of the methods which are now commonly used
This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug deve
The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive seq